Goldman Sachs Group Inc Axogen, Inc. Transaction History
Goldman Sachs Group Inc
- $706 Billion
- Q2 2025
A detailed history of Goldman Sachs Group Inc transactions in Axogen, Inc. stock. As of the latest transaction made, Goldman Sachs Group Inc holds 237,841 shares of AXGN stock, worth $3.88 Million. This represents 0.0% of its overall portfolio holdings.
Number of Shares
237,841
Previous 272,814
12.82%
Holding current value
$3.88 Million
Previous $5.05 Million
48.88%
% of portfolio
0.0%
Previous 0.0%
Shares
22 transactions
Others Institutions Holding AXGN
# of Institutions
171Shares Held
40.4MCall Options Held
69.1KPut Options Held
0-
First Light Asset Management, LLC Edina, MN4.53MShares$73.8 Million7.55% of portfolio
-
Black Rock Inc. New York, NY3.25MShares$53 Million0.0% of portfolio
-
Vanguard Group Inc Valley Forge, PA2.73MShares$44.5 Million0.0% of portfolio
-
Morgan Stanley New York, NY2.51MShares$40.9 Million0.0% of portfolio
-
Balyasny Asset Management LLC Chicago, IL1.93MShares$31.5 Million0.03% of portfolio
About Axogen, Inc.
- Ticker AXGN
- Exchange NASDAQ
- Sector Healthcare
- Industry Medical Devices
- Shares Outstandng 42,283,700
- Market Cap $689M
- Description
- AxoGen, Inc., together with its subsidiaries, develops and markets surgical solutions for physical damage or transection to peripheral nerves. The company's products include Avance Nerve Graft, a biologically active off-the-shelf processed human nerve allograft for bridging severed nerves without the comorbidities associated with a second surgic...